X. Masramón

621 total citations
17 papers, 453 citations indexed

About

X. Masramón is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Surgery. According to data from OpenAlex, X. Masramón has authored 17 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cognitive Neuroscience, 5 papers in Psychiatry and Mental health and 3 papers in Surgery. Recurrent topics in X. Masramón's work include Pain Management and Placebo Effect (4 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers) and Neurological disorders and treatments (2 papers). X. Masramón is often cited by papers focused on Pain Management and Placebo Effect (4 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers) and Neurological disorders and treatments (2 papers). X. Masramón collaborates with scholars based in Spain, United States and Australia. X. Masramón's co-authors include Yolanda de la Llave, Gemzel Hernandez, Diego García‐Borreguero, Oscar Larrosa, Gonzalo Hernández, Miguel Pocovı́, J. M. Sol, Fernando Civeira, Elena Casals and Ramón Gomis and has published in prestigious journals such as Neurology, Metabolism and Diabetic Medicine.

In The Last Decade

X. Masramón

15 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
X. Masramón Spain 7 236 215 202 63 56 17 453
Houzhen Tuo China 11 93 0.4× 96 0.4× 50 0.2× 32 0.5× 21 0.4× 36 452
M Giroud France 11 25 0.1× 62 0.3× 54 0.3× 126 2.0× 37 0.7× 41 405
Ana Lúcia Zuma de Rosso Brazil 14 40 0.2× 372 1.7× 48 0.2× 47 0.7× 28 0.5× 48 533
Coleen Hall United States 11 483 2.0× 434 2.0× 47 0.2× 58 0.9× 10 0.2× 18 927
Mark Oppenheimer United States 9 86 0.4× 45 0.2× 21 0.1× 19 0.3× 33 0.6× 14 303
J Spencer United Kingdom 12 74 0.3× 36 0.2× 27 0.1× 15 0.2× 171 3.1× 31 434
Harli Grant United States 7 49 0.2× 92 0.4× 34 0.2× 118 1.9× 11 0.2× 12 307
Sanjib Sinha India 9 21 0.1× 48 0.2× 52 0.3× 33 0.5× 9 0.2× 25 330
Eric Reimund United States 8 55 0.2× 13 0.1× 111 0.5× 8 0.1× 33 0.6× 12 338
Xiaoqun Zhu China 10 36 0.2× 35 0.2× 82 0.4× 83 1.3× 6 0.1× 45 291

Countries citing papers authored by X. Masramón

Since Specialization
Citations

This map shows the geographic impact of X. Masramón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Masramón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Masramón more than expected).

Fields of papers citing papers by X. Masramón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X. Masramón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Masramón. The network helps show where X. Masramón may publish in the future.

Co-authorship network of co-authors of X. Masramón

This figure shows the co-authorship network connecting the top 25 collaborators of X. Masramón. A scholar is included among the top collaborators of X. Masramón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with X. Masramón. X. Masramón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Masramón, X., et al.. (2008). PMS1 COGNITIVE IMPAIRMENT IN PATIENTS WITH FIBROMYALGIA SYNDROME AS ASSESSED BY THE MINIMENTAL STATE EXAMINATION. Value in Health. 11(6). A536–A536. 3 indexed citations
3.
Peña, Pilar, et al.. (2008). Pautas terapéuticas en el paciente con epilepsia farmacorresistente en consultas ambulatorias de neurología y epilepsia en España. Revista de Neurología. 47(10). 517–517. 9 indexed citations
4.
Zamorano, José Luis, Luis Rodrı́guez Padial, Juan Cosín, et al.. (2008). Amlodipine Reduces Predicted Risk of Coronary Heart Disease in High-Risk Patients with Hypertension in Spain (The CORONARIA Study). Journal of International Medical Research. 36(6). 1399–1417. 1 indexed citations
5.
Arango, Celso, Manuel Gómez-Beneyto, Cristòbal Gastó, et al.. (2007). A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia. European Neuropsychopharmacology. 17(6-7). 456–463. 10 indexed citations
6.
7.
8.
9.
Rejas, Javier, et al.. (2005). PPN10 PSYCHOMETRIC PROPERTIES OF THE MOS-SLEEP SCALE IN NEUROPATHIC PAIN (NEP) SYNDROMES. Value in Health. 8(6). A142–A143. 1 indexed citations
10.
Blercom, N. Van, et al.. (2004). Effects of Gabapentin on the Motor Response to Levodopa. Clinical Neuropharmacology. 27(3). 124–128. 27 indexed citations
11.
12.
Gálvez, Rafael, et al.. (2004). PNL23 CHRONIC NEUROPATHIC PAIN (NEP) IMPACT ON PATIENT QUALITY OF LIFE AND DISABILITY: RESULTS FROM THE DONEGA STUDY. Value in Health. 7(6). 794–794. 1 indexed citations
13.
Costa, Andréa Miúra da, Roser Casamitjana, Elena Casals, et al.. (2003). Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C‐reactive protein in subjects with impaired fasting glucose. Diabetic Medicine. 20(9). 743–745. 50 indexed citations
14.
García-Otín, A.L., Fernando Civeira, Cèsar Díaz‐Torné, et al.. (2002). Allelic polymorphism −491A/T in apo E gene modulates the lipid‐lowering response in combined hyperlipidemia treatment. European Journal of Clinical Investigation. 32(6). 421–428. 22 indexed citations
15.
García‐Borreguero, Diego, et al.. (2002). Treatment of restless legs syndrome with gabapentin. Neurology. 59(10). 1573–1579. 273 indexed citations
16.
Cenarro, Ana, Fernando Civeira, Cristina Dı́az, et al.. (2001). Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: Effect of the lipid-lowering agents, atorvastatin and bezafibrate. Metabolism. 50(4). 447–450. 43 indexed citations
17.
Sol, J. M., et al.. (2000). Efficacy and Safety of Quinapril 40mg Once Daily as Monotherapy for Patients with Poorly Controlled Hypertension. Clinical Drug Investigation. 20(2). 81–88. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Houzhen Tuo Breakdown of academic impact, for papers by M Giroud Breakdown of academic impact, for papers by Ana Lúcia Zuma de Rosso Breakdown of academic impact, for papers by Coleen Hall Breakdown of academic impact, for papers by Mark Oppenheimer Breakdown of academic impact, for papers by J Spencer Breakdown of academic impact, for papers by Harli Grant Breakdown of academic impact, for papers by Sanjib Sinha Breakdown of academic impact, for papers by Eric Reimund Breakdown of academic impact, for papers by Xiaoqun Zhu
Rankless by CCL
2026